Design your branded product microsite header
Date/Time: September 28, 2023 | 1:00 - 1:30 pm ET
In this sponsored session, learners will review the importance and benefits of early diagnosis and therapy in sepsis patients. The presenter will also review evidence indicating that patient deterioration is preceded by hours of warning signs. Attendees will then discover clinical decision support surveillance technology options that may facilitate care and augment an already strained clinical staff.
Sponsored by GE HealthCare
John “JW” Beard, MD, is a board-certified anesthesiologist and the Chief Medical Officer of GE HealthCare – Patient Care Solutions (PCS). PCS technologies include patient monitoring, anesthesia delivery, respiratory care, diagnostic cardiology, maternal infant care, and digital health products and services. Dr. Beard is responsible for contributing clinical expertise to strategic business processes including innovation, clinical evidence development, health economics research, and scientific communication. Prior to GE, Dr. Beard served as Chief Medical Officer for ICU Medical, Inc. He has fifteen years of clinical practice experience, including roles in pre-admission clinics, operating rooms, pain management services, intensive care, and labor and delivery units. During his clinical practice, he led multiple quality improvement initiatives and held leadership positions including Chairman and Medical Director of the Department of Anesthesiology. His clinical experience has been enriched by providing volunteer medical care in the Americas, Asia, and Africa.
Session Title: GE Healthcare Sponsored Session: Data Aggregation, Clinical Decision Support, and the Early Recognition and Therapy of Sepsis
Session Day/Time: Thursday, September 28, 2023, 1:00 PM - 1:30 PM EST
Click here to register for Sepsis Alliance Summit.